Skip to main content
Journal cover image

Treating patients with acute coronary syndromes with aggressive antiplatelet therapy (from the Global Registry of Acute Coronary Events).

Publication ,  Journal Article
Lim, MJ; Eagle, KA; Gore, JM; Anderson, FA; Dabbous, OH; Mehta, RH; Granger, CB; Fox, KAA; Spencer, FA; Goldberg, RJ ...
Published in: Am J Cardiol
October 1, 2005

Few data exist on the use of aggressive combination therapy with thienopyridines and glycoprotein IIb/IIIa inhibitors in higher risk patients with an acute coronary syndrome (ACS). The aim of this study was to characterize the combined use of these agents and the associated hospital outcomes in patients with ACS enrolled in the multinational Global Registry of Acute Coronary Events. Data from 8,081 patients with non-ST-segment elevation myocardial infarction or unstable angina were analyzed. Of these patients, 5,070 (62.7%) received aspirin and a thienopyridine, and the remainder received aspirin, a thienopyridine, and a glycoprotein IIb/IIIa blocker. The presence of a non-ST-segment elevation myocardial infarction; a history of diabetes or coronary artery bypass surgery; performance of in-hospital catheterization, percutaneous coronary intervention, or coronary artery bypass grafting; and in-hospital use of heparin were independent predictors of the use of triple antiplatelet therapy with aspirin, thienopyridines, and glycoprotein IIb/IIIa blockers. Increased diastolic blood pressure and increased serum creatinine were associated with a failure to prescribe triple therapy. An increased risk of major bleeding during hospitalization was associated with the use of triple antiplatelet therapy (odds ratio 1.6, 95% confidence interval 1.2 to 2.2). Aggressive antiplatelet therapy was used in approximately 2 of every 5 patients presenting with an ACS. Triple therapy was associated with the performance of catheterization and/or percutaneous coronary intervention, as well as high-risk patient features. Although no differences in hospital death rates were evident in patients receiving triple therapy, this population was at significantly increased risk of major bleeding episodes during hospitalization.

Duke Scholars

Published In

Am J Cardiol

DOI

ISSN

0002-9149

Publication Date

October 1, 2005

Volume

96

Issue

7

Start / End Page

917 / 921

Location

United States

Related Subject Headings

  • Pyridines
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Platelet Aggregation Inhibitors
  • Myocardial Infarction
  • Middle Aged
  • Male
  • Humans
  • Female
  • Electrocardiography
  • Drug Therapy, Combination
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Lim, M. J., Eagle, K. A., Gore, J. M., Anderson, F. A., Dabbous, O. H., Mehta, R. H., … Global Registry of Acute Coronary Events Investigators, . (2005). Treating patients with acute coronary syndromes with aggressive antiplatelet therapy (from the Global Registry of Acute Coronary Events). Am J Cardiol, 96(7), 917–921. https://doi.org/10.1016/j.amjcard.2005.05.047
Lim, Michael J., Kim A. Eagle, Joel M. Gore, Frederick A. Anderson, Omar H. Dabbous, Rajendra H. Mehta, Christopher B. Granger, et al. “Treating patients with acute coronary syndromes with aggressive antiplatelet therapy (from the Global Registry of Acute Coronary Events).Am J Cardiol 96, no. 7 (October 1, 2005): 917–21. https://doi.org/10.1016/j.amjcard.2005.05.047.
Lim MJ, Eagle KA, Gore JM, Anderson FA, Dabbous OH, Mehta RH, et al. Treating patients with acute coronary syndromes with aggressive antiplatelet therapy (from the Global Registry of Acute Coronary Events). Am J Cardiol. 2005 Oct 1;96(7):917–21.
Lim, Michael J., et al. “Treating patients with acute coronary syndromes with aggressive antiplatelet therapy (from the Global Registry of Acute Coronary Events).Am J Cardiol, vol. 96, no. 7, Oct. 2005, pp. 917–21. Pubmed, doi:10.1016/j.amjcard.2005.05.047.
Lim MJ, Eagle KA, Gore JM, Anderson FA, Dabbous OH, Mehta RH, Granger CB, Fox KAA, Spencer FA, Goldberg RJ, Global Registry of Acute Coronary Events Investigators. Treating patients with acute coronary syndromes with aggressive antiplatelet therapy (from the Global Registry of Acute Coronary Events). Am J Cardiol. 2005 Oct 1;96(7):917–921.
Journal cover image

Published In

Am J Cardiol

DOI

ISSN

0002-9149

Publication Date

October 1, 2005

Volume

96

Issue

7

Start / End Page

917 / 921

Location

United States

Related Subject Headings

  • Pyridines
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Platelet Aggregation Inhibitors
  • Myocardial Infarction
  • Middle Aged
  • Male
  • Humans
  • Female
  • Electrocardiography
  • Drug Therapy, Combination